Return to Listing

1 result(s) for Thyrogen

PI Name Protocol # Title
Matthew Taylor IRB00009480 A Randomized, Double Blind Study to Compare the Complete Remission Rate Following a 5-Week Course of Selumetinib or Placebo and Single Dose Adjuvant Radioactive Iodine Therapy in Patients with Differentiated Thyroid Cancer

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080